China plans to set up a state catalog for medicines in short supply to strengthen early warning on medicine shortage and ensure drug supply, according to a draft government regulation.
Xu Jinghe, deputy commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Yasuhiro Fujiwara, chief executive of Japan's Pharmaceuticals and Medical Devices Agency (PMDA) on Jan 7, 2020.
The National Medical Products Administration (NMPA) has given the go-ahead for the launch of China's first self-developed 13-valent pneumonia vaccine to better protect babies from a leading cause of death.
- The State Council's Leading Group for Deepening the Reform of the Medical and Health System Issued the Notice on Policies and Measures to Further Deepen the Reform of the Medical and Health System with Centralized Procurement & Use of Drugs as a Breakthrough
- NMPA Issued the Notice on the Implementation Plan of the State Council for Full-Coverage Pilot Reform of Separated Management of Permit and License in the Free Trade Pilot Areas
- NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions